Cardiovascular Clinical Trial Expertise


ESTERN Medical CRO offers services in the cardiovascular therapeutic area from Clinical “Phase I through Phase IV” and, to date, has conducted diverse international studies. Cardiovascular trials have been conducted in US-North America & Latin America e.g., Mexico, Colombia, Chile, Argentina and Brazil including diverse areas of Angiography -Interventional Cardiology, MRI, MRA and CT.

Our strength in cardiovascular disease comes from lead staff that is experienced in the clinical development of cardiovascular disease pharmaceutical and medical device treatments, our access to opinion leaders and trials networks worldwide, our extensive proprietary investigator database and lastly, our global operational expertise in running multi-national trials.

Within the field of cardiology, ESTERN Medical has specific experience in conducting complex pivotal studies in indications such as:

  • Hyperlipidemia
  • Hypertension
  • Coronary artery disease
  • Peripheral arterial occlusion
  • Venous thromboembolism
  • Pulmonary arterial hypertension
  • Acute myocardial infarction
  • Angina
  • Atrial fibrillation

Congestive heart failure

Our experience extends to a broad range of pharmacologic classes/treatments.

Our US-North American & Latin American investigator proprietary database includes abroad cardiologists list of key opinion leaders, and our association with leading cardiology sites in the US & Latin America enables efficient subject recruitment to match study protocol requirements.

Our clinical trial experience also includes:

Cardiovascular Device Trial Expertise:

Whether treating chronic heart failure or finding improved technologies to reconnect arteries, ESTERN Medical has extensive experience in managing device projects, including:

  • Drug-eluting stents
  • Radiation therapies
  • Distal protection devices

Our Cardiology Expertise

Our Cardiology & Pulmonary Expertise

Pulmonary & Allergy Clinical Studies

ESTERN Medical´s experience in pulmonary/allergy clinical research encompasses multiple indications with significant expertise in the conduct of asthma, allergic rhinitis and COPD. Together, these three indications account for a broad percentage of ESTERN Medical respiratory/allergy experience. In addition, we have significant knowledge and experience in many pulmonary function tests including centralized review and quality assurance of pulmonary function test data.

ESTERN Medical has a track record of participation in the development of most marketed pulmonary & allergy drugs for diverse pathologies, including:

  • Acute sinusitis
  • Allergic rhinitis
  • Asthma
  • Chronic obstructive pulmonary disease
  • Chronic sinusitis
  • Emphysema
  • Malignant neoplasm of trachea, bronchus and lung
  • Other diseases of lung and respiratory system
  • Viral and chlamydial infection